Hideki Ueno

1.0k total citations
44 papers, 706 citations indexed

About

Hideki Ueno is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hideki Ueno has authored 44 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 15 papers in Surgery and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hideki Ueno's work include Pancreatic and Hepatic Oncology Research (23 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Neuroendocrine Tumor Research Advances (9 papers). Hideki Ueno is often cited by papers focused on Pancreatic and Hepatic Oncology Research (23 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Neuroendocrine Tumor Research Advances (9 papers). Hideki Ueno collaborates with scholars based in Japan, United States and Philippines. Hideki Ueno's co-authors include Shunsuke Kondo, Takuji Okusaka, Chigusa Morizane, Masafumi Ikeda, Shuichi Mitsunaga, Yasunari Sakamoto, Kenji Tamura, Kazuaki Shimada, Kohei Nakachi and Fumiaki Koizumi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Hideki Ueno

41 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Ueno Japan 14 389 192 168 160 140 44 706
Laurence P. Diggs United States 14 391 1.0× 185 1.0× 131 0.8× 99 0.6× 173 1.2× 37 823
Xiaowei Dang China 12 224 0.6× 163 0.8× 123 0.7× 95 0.6× 165 1.2× 33 509
Zhixiang Jian China 17 335 0.9× 206 1.1× 180 1.1× 195 1.2× 211 1.5× 38 781
Jing‐Yun Wen China 13 255 0.7× 172 0.9× 199 1.2× 175 1.1× 81 0.6× 36 594
Richard Létourneau Canada 11 764 2.0× 210 1.1× 286 1.7× 166 1.0× 280 2.0× 26 1.0k
Vincenzo Dadduzio Italy 18 451 1.2× 164 0.9× 181 1.1× 297 1.9× 258 1.8× 39 834
Bolorsukh Gansukh United States 6 261 0.7× 204 1.1× 200 1.2× 421 2.6× 141 1.0× 8 847
Michele Basso Italy 18 521 1.3× 177 0.9× 212 1.3× 292 1.8× 251 1.8× 47 839
De-Sen Wan China 18 655 1.7× 214 1.1× 190 1.1× 64 0.4× 148 1.1× 40 972
Dana A. Dominguez United States 12 206 0.5× 223 1.2× 188 1.1× 129 0.8× 148 1.1× 39 685

Countries citing papers authored by Hideki Ueno

Since Specialization
Citations

This map shows the geographic impact of Hideki Ueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Ueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Ueno more than expected).

Fields of papers citing papers by Hideki Ueno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Ueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Ueno. The network helps show where Hideki Ueno may publish in the future.

Co-authorship network of co-authors of Hideki Ueno

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Ueno. A scholar is included among the top collaborators of Hideki Ueno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Ueno. Hideki Ueno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maruki, Yuta, Chigusa Morizane, Yoshikuni Nagashio, et al.. (2025). First Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma with Tasurgratinib Following Regulatory Approval: A Case Report from Clinical Practice. International Journal of Molecular Sciences. 26(12). 5586–5586.
2.
Hijioka, Susumu, Yoshikuni Nagashio, Yuta Maruki, et al.. (2024). Incidence and factors associated with stent dysfunction and pancreatitis after gastroduodenal stenting for malignant gastric outlet obstruction. SHILAP Revista de lepidopterología. 12(3). E367–E376. 2 indexed citations
3.
4.
5.
Hijioka, Susumu, Yoshikuni Nagashio, Yuta Maruki, et al.. (2024). Feasibility and safety of a novel plastic stent designed specifically for endoscopic ultrasound-guided pancreatic duct drainage. SHILAP Revista de lepidopterología. 12(6). E715–E722. 2 indexed citations
6.
Morizane, Chigusa, Noriko Tanabe, Yuta Maruki, et al.. (2023). Clinical features of germline BRCA1/2 or ATM pathogenic variant positive pancreatic cancer in Japan. Pancreatology. 23(8). 964–969. 6 indexed citations
7.
8.
Okuyama, Hiroyuki, Masafumi Ikeda, Hideaki Takahashi, et al.. (2017). Transarterial (Chemo)Embolization for Liver Metastases in Patients with Neuroendocrine Tumors. Oncology. 92(6). 353–359. 10 indexed citations
9.
Kondo, Shunsuke, Akihiro Ohba, Mitsuhito Sasaki, et al.. (2017). Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment. Oncology. 94(2). 72–78. 11 indexed citations
10.
Ikeda, Masafumi, Hideaki Takahashi, Shunsuke Kondo, et al.. (2017). Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 79(6). 1169–1177. 38 indexed citations
11.
Shoji, Hirokazu, Chigusa Morizane, Yasunari Sakamoto, et al.. (2015). Phase I clinical trial of oral administration of S-1 in combination with intravenous gemcitabine and cisplatin in patients with advanced biliary tract cancer. Japanese Journal of Clinical Oncology. 46(2). hyv179–hyv179. 6 indexed citations
12.
Mitsunaga, Shuichi, Masafumi Ikeda, Satoshi Shimizu, et al.. (2015). C-Reactive Protein Level Is an Indicator of the Aggressiveness of Advanced Pancreatic Cancer. Pancreas. 45(1). 110–116. 30 indexed citations
13.
Terazawa, Tetsuji, Shunsuke Kondo, Chigusa Morizane, et al.. (2014). Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial. BMC Cancer. 14(1). 301–301. 9 indexed citations
14.
Ikeda, Masafumi, Shuichi Mitsunaga, Satoshi Shimizu, et al.. (2013). Efficacy of sorafenib in patients with hepatocellular carcinoma refractory to transcatheter arterial chemoembolization. Journal of Gastroenterology. 49(5). 932–940. 35 indexed citations
15.
Mayahara, Hiroshi, Yoshinori Ito, Chigusa Morizane, et al.. (2012). Salvage chemoradiotherapy after primary chemotherapy for locally advanced pancreatic cancer: a single-institution retrospective analysis. BMC Cancer. 12(1). 609–609. 11 indexed citations
16.
Kondo, Shunsuke, Hidenori Ojima, Hitoshi Tsuda, et al.. (2012). Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma. International Journal of Clinical Oncology. 18(2). 207–213. 72 indexed citations
17.
Iwasa, Satoru, Masafumi Ikeda, Takuji Okusaka, et al.. (2011). Transcatheter Arterial Infusion Chemotherapy with a Fine-powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization. Japanese Journal of Clinical Oncology. 41(6). 770–775. 27 indexed citations
18.
Morita‐Hoshi, Yuriko, Yasushi Kojima, Hideki Ueno, et al.. (2010). Long-Term Administration of Wilms Tumor-1 Peptide Vaccine in Combination with Gemcitabine Causes Severe Local Skin Inflammation at Injection Sites. Japanese Journal of Clinical Oncology. 40(12). 1184–1188. 5 indexed citations
19.
Sugiyama, Emiko, Nahoko Kaniwa, Su-Ryang Kim, et al.. (2010). Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients. Clinical Pharmacokinetics. 49(8). 549–558. 49 indexed citations
20.
Hashimoto, Kenji, Hideki Ueno, Masafumi Ikeda, et al.. (2009). Do Recurrent and Metastatic Pancreatic Cancer Patients Have the Same Outcomes with Gemcitabine Treatment?. Oncology. 77(3-4). 217–223. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurence P. Diggs Breakdown of academic impact, for papers by Xiaowei Dang Breakdown of academic impact, for papers by Zhixiang Jian Breakdown of academic impact, for papers by Jing‐Yun Wen Breakdown of academic impact, for papers by Richard Létourneau Breakdown of academic impact, for papers by Vincenzo Dadduzio Breakdown of academic impact, for papers by Bolorsukh Gansukh Breakdown of academic impact, for papers by Michele Basso Breakdown of academic impact, for papers by De-Sen Wan Breakdown of academic impact, for papers by Dana A. Dominguez
Rankless by CCL
2026